US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 1.580
  • 0.0000.00%
Close Mar 28 16:00 ET
  • 1.560
  • -0.020-1.27%
Post 19:37 ET
389.98MMarket Cap-2925P/E (TTM)

Adaptimmune Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
122.05%60.28M
-97.91%231K
4.45%7.32M
-7.37%5.13M
1,231.50%47.6M
341.50%27.15M
678.26%11.03M
482.46%7.01M
78.93%5.54M
723.73%3.58M
Operating revenue
122.05%60.28M
-97.91%231K
4.45%7.32M
-7.37%5.13M
1,231.50%47.6M
341.50%27.15M
678.26%11.03M
482.46%7.01M
78.93%5.54M
723.73%3.58M
Cost of revenue
Gross profit
Operating expense
5.03%198.32M
39.23%50.09M
7.91%53.95M
1.52%50.04M
-17.39%44.24M
12.13%188.82M
-18.76%35.97M
15.24%50M
16.23%49.29M
39.75%53.56M
Selling and administrative expenses
17.55%71.81M
30.63%16.88M
-3.87%16.16M
37.96%20.07M
11.25%18.69M
6.61%61.09M
-12.55%12.92M
10.82%16.82M
7.47%14.55M
21.62%16.8M
-General and administrative expense
17.55%71.81M
30.63%16.88M
-3.87%16.16M
37.96%20.07M
11.25%18.69M
6.61%61.09M
-12.55%12.92M
10.82%16.82M
7.47%14.55M
21.62%16.8M
Research and development costs
-0.95%126.51M
44.06%33.21M
13.88%37.79M
-13.74%29.97M
-30.49%25.55M
14.98%127.73M
-21.87%23.05M
17.62%33.18M
20.34%34.74M
49.97%36.75M
Operating profit
14.62%-138.04M
-99.86%-49.86M
-8.47%-46.63M
-2.64%-44.91M
106.72%3.36M
0.36%-161.67M
41.80%-24.95M
-1.92%-42.99M
-11.29%-43.75M
-31.91%-49.98M
Net non-operating interest income expense
286.77%5.96M
205.16%1.6M
563.27%2.15M
332.21%1.54M
100.00%676K
40.82%1.54M
192.18%523K
44.00%324K
34.21%357K
-20.47%338K
Non-operating interest income
286.77%5.96M
205.16%1.6M
563.27%2.15M
332.21%1.54M
100.00%676K
40.82%1.54M
192.18%523K
44.00%324K
34.21%357K
-20.47%338K
Other net income (expense)
789.69%19.54M
91.84%-313K
-126.16%-430K
3,558.93%22.66M
-19,883.33%-2.37M
-173.55%-2.83M
-195.00%-3.83M
793.67%1.64M
-1,312.96%-655K
1,300.00%12K
Special income (charges)
985.76%20.35M
--0
---106K
--22.16M
---1.7M
---2.3M
---2.3M
--0
--0
--0
-Less:Restructuring and merger&acquisition
-985.76%-20.35M
--0
--106K
---22.16M
--1.7M
--2.3M
--2.3M
--0
--0
--0
Other non- operating income (expenses)
-50.56%-807K
79.64%-313K
-119.71%-324K
176.49%501K
-5,691.67%-671K
-113.91%-536K
-138.08%-1.54M
793.67%1.64M
-1,312.96%-655K
1,300.00%12K
Income before tax
30.94%-112.54M
-71.90%-48.57M
-9.49%-44.91M
52.99%-20.71M
103.35%1.66M
-3.60%-162.96M
26.89%-28.26M
2.78%-41.02M
-12.97%-44.05M
-32.47%-49.63M
Income tax
-46.50%1.34M
-166.00%-656K
72.18%687K
44.68%680K
-1.42%625K
215.68%2.5M
375.60%994K
91.83%399K
518.42%470K
112.75%634K
Net income
31.18%-113.87M
-63.82%-47.92M
-10.09%-45.6M
51.96%-21.39M
102.06%1.04M
-4.66%-165.46M
24.73%-29.25M
2.31%-41.42M
-13.96%-44.52M
-33.11%-50.27M
Net income continuous Operations
31.18%-113.87M
-63.82%-47.92M
-10.09%-45.6M
51.96%-21.39M
102.06%1.04M
-4.66%-165.46M
24.73%-29.25M
2.31%-41.42M
-13.96%-44.52M
-33.11%-50.27M
Minority interest income
Net income attributable to the parent company
31.18%-113.87M
-63.82%-47.92M
-10.09%-45.6M
51.96%-21.39M
102.06%1.04M
-4.66%-165.46M
24.73%-29.25M
2.31%-41.42M
-13.96%-44.52M
-33.11%-50.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
31.18%-113.87M
-63.82%-47.92M
-10.09%-45.6M
51.96%-21.39M
102.06%1.04M
-4.66%-165.46M
24.73%-29.25M
2.31%-41.42M
-13.96%-44.52M
-33.11%-50.27M
Basic earnings per share
47.06%-0.54
0.00%-0.18
25.00%-0.18
60.00%-0.12
102.09%0.0063
0.00%-1.02
25.00%-0.18
20.00%-0.24
-25.00%-0.3
-25.00%-0.3
Diluted earnings per share
47.06%-0.54
0.00%-0.18
25.00%-0.18
60.00%-0.12
102.07%0.0062
0.00%-1.02
25.00%-0.18
20.00%-0.24
-25.00%-0.3
-25.00%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 122.05%60.28M-97.91%231K4.45%7.32M-7.37%5.13M1,231.50%47.6M341.50%27.15M678.26%11.03M482.46%7.01M78.93%5.54M723.73%3.58M
Operating revenue 122.05%60.28M-97.91%231K4.45%7.32M-7.37%5.13M1,231.50%47.6M341.50%27.15M678.26%11.03M482.46%7.01M78.93%5.54M723.73%3.58M
Cost of revenue
Gross profit
Operating expense 5.03%198.32M39.23%50.09M7.91%53.95M1.52%50.04M-17.39%44.24M12.13%188.82M-18.76%35.97M15.24%50M16.23%49.29M39.75%53.56M
Selling and administrative expenses 17.55%71.81M30.63%16.88M-3.87%16.16M37.96%20.07M11.25%18.69M6.61%61.09M-12.55%12.92M10.82%16.82M7.47%14.55M21.62%16.8M
-General and administrative expense 17.55%71.81M30.63%16.88M-3.87%16.16M37.96%20.07M11.25%18.69M6.61%61.09M-12.55%12.92M10.82%16.82M7.47%14.55M21.62%16.8M
Research and development costs -0.95%126.51M44.06%33.21M13.88%37.79M-13.74%29.97M-30.49%25.55M14.98%127.73M-21.87%23.05M17.62%33.18M20.34%34.74M49.97%36.75M
Operating profit 14.62%-138.04M-99.86%-49.86M-8.47%-46.63M-2.64%-44.91M106.72%3.36M0.36%-161.67M41.80%-24.95M-1.92%-42.99M-11.29%-43.75M-31.91%-49.98M
Net non-operating interest income expense 286.77%5.96M205.16%1.6M563.27%2.15M332.21%1.54M100.00%676K40.82%1.54M192.18%523K44.00%324K34.21%357K-20.47%338K
Non-operating interest income 286.77%5.96M205.16%1.6M563.27%2.15M332.21%1.54M100.00%676K40.82%1.54M192.18%523K44.00%324K34.21%357K-20.47%338K
Other net income (expense) 789.69%19.54M91.84%-313K-126.16%-430K3,558.93%22.66M-19,883.33%-2.37M-173.55%-2.83M-195.00%-3.83M793.67%1.64M-1,312.96%-655K1,300.00%12K
Special income (charges) 985.76%20.35M--0---106K--22.16M---1.7M---2.3M---2.3M--0--0--0
-Less:Restructuring and merger&acquisition -985.76%-20.35M--0--106K---22.16M--1.7M--2.3M--2.3M--0--0--0
Other non- operating income (expenses) -50.56%-807K79.64%-313K-119.71%-324K176.49%501K-5,691.67%-671K-113.91%-536K-138.08%-1.54M793.67%1.64M-1,312.96%-655K1,300.00%12K
Income before tax 30.94%-112.54M-71.90%-48.57M-9.49%-44.91M52.99%-20.71M103.35%1.66M-3.60%-162.96M26.89%-28.26M2.78%-41.02M-12.97%-44.05M-32.47%-49.63M
Income tax -46.50%1.34M-166.00%-656K72.18%687K44.68%680K-1.42%625K215.68%2.5M375.60%994K91.83%399K518.42%470K112.75%634K
Net income 31.18%-113.87M-63.82%-47.92M-10.09%-45.6M51.96%-21.39M102.06%1.04M-4.66%-165.46M24.73%-29.25M2.31%-41.42M-13.96%-44.52M-33.11%-50.27M
Net income continuous Operations 31.18%-113.87M-63.82%-47.92M-10.09%-45.6M51.96%-21.39M102.06%1.04M-4.66%-165.46M24.73%-29.25M2.31%-41.42M-13.96%-44.52M-33.11%-50.27M
Minority interest income
Net income attributable to the parent company 31.18%-113.87M-63.82%-47.92M-10.09%-45.6M51.96%-21.39M102.06%1.04M-4.66%-165.46M24.73%-29.25M2.31%-41.42M-13.96%-44.52M-33.11%-50.27M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 31.18%-113.87M-63.82%-47.92M-10.09%-45.6M51.96%-21.39M102.06%1.04M-4.66%-165.46M24.73%-29.25M2.31%-41.42M-13.96%-44.52M-33.11%-50.27M
Basic earnings per share 47.06%-0.540.00%-0.1825.00%-0.1860.00%-0.12102.09%0.00630.00%-1.0225.00%-0.1820.00%-0.24-25.00%-0.3-25.00%-0.3
Diluted earnings per share 47.06%-0.540.00%-0.1825.00%-0.1860.00%-0.12102.07%0.00620.00%-1.0225.00%-0.1820.00%-0.24-25.00%-0.3-25.00%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg